SILVERARC CAPITAL MANAGEMENT, LLC Crinetics Pharmaceuticals, Inc. Transaction History

SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:

$2.92M
portfolio value

SILVERARC CAPITAL MANAGEMENT, LLC quarter portfolio value change:

+5.31%
quarter

Crinetics Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +6.80% 9.48K shares 325K $19.64 149.02K
Q2 2022 share Increase +22.40% 25.53K shares 100K $18.65 139.53K
Q1 2022 share Increase +1.92% 2.14K shares -676K $21.95 114.00K
Q4 2021 share Increase +126.52% 62.47K shares 2.13M $28.03 111.86K
Q3 2021 share Increase 0.00% 49.38K shares 1.03M $21.05 49.38K